id	sid	eid	entity	type
ajlm-1261	1	1	adeyemi t. adeyemo department of medical	ORG
ajlm-1261	1	2	obafemi awolowo university teaching hospitals	ORG
ajlm-1261	1	3	nigeria	GPE
ajlm-1261	2	1	kolawole department of medicine	ORG
ajlm-1261	2	2	awolowo university	ORG
ajlm-1261	2	3	nigeria	GPE
ajlm-1261	2	4	vincent o. rotimi department	PERSON
ajlm-1261	2	5	kuwait university	ORG
ajlm-1261	2	6	kuwait city	GPE
ajlm-1261	3	1	kuwait	GPE
ajlm-1261	3	2	aaron o.	PERSON
ajlm-1261	4	1	obafemi awolowo university teaching hospitals	ORG
ajlm-1261	4	2	nigeria department of medical	ORG
ajlm-1261	4	3	awolowo university	ORG
ajlm-1261	4	4	nigeria	GPE
ajlm-1261	4	5	kolawole	PERSON
ajlm-1261	4	6	rotimi vo	ORG
ajlm-1261	4	7	aboderin ao.	GPE
ajlm-1261	6	1	afr j	PERSON
ajlm-1261	7	1	2021;10(1	CARDINAL
ajlm-1261	7	2	t. adeyemo	GPE
ajlm-1261	7	3	babatope kolawole	PERSON
ajlm-1261	7	4	vincent o. rotimi	PERSON
ajlm-1261	7	5	aaron o.	PERSON
ajlm-1261	7	6	03	CARDINAL
ajlm-1261	7	7	22	CARDINAL
ajlm-1261	7	8	oct. 2020	DATE
ajlm-1261	8	1	23	CARDINAL
ajlm-1261	8	2	2021	CARDINAL
ajlm-1261	8	3	2021	CARDINAL
ajlm-1261	13	1	west african	NORP
ajlm-1261	14	1	osun state	GPE
ajlm-1261	14	2	nigeria	GPE
ajlm-1261	14	3	between july 2016	DATE
ajlm-1261	14	4	april 2017	DATE
ajlm-1261	18	1	218	CARDINAL
ajlm-1261	18	2	93	CARDINAL
ajlm-1261	18	3	129	CARDINAL
ajlm-1261	18	4	59.2%	PERCENT
ajlm-1261	18	5	gram	CARDINAL
ajlm-1261	18	6	59	DATE
ajlm-1261	18	7	27.1%	PERCENT
ajlm-1261	18	8	gram	CARDINAL
ajlm-1261	18	9	29	CARDINAL
ajlm-1261	18	10	13.3%	PERCENT
ajlm-1261	19	1	five	CARDINAL
ajlm-1261	19	2	34	CARDINAL
ajlm-1261	19	3	15.6%	PERCENT
ajlm-1261	19	4	23	CARDINAL
ajlm-1261	19	5	10.6%	PERCENT
ajlm-1261	19	6	20	CARDINAL
ajlm-1261	19	7	9.2%	PERCENT
ajlm-1261	19	8	19	CARDINAL
ajlm-1261	19	9	8.7%	PERCENT
ajlm-1261	20	1	19	CARDINAL
ajlm-1261	20	2	8.7%	PERCENT
ajlm-1261	22	1	7	CARDINAL
ajlm-1261	22	2	3.2%	PERCENT
ajlm-1261	22	3	6	CARDINAL
ajlm-1261	22	4	2.8%	PERCENT
ajlm-1261	23	1	seventy-four	CARDINAL
ajlm-1261	23	2	80%	PERCENT
ajlm-1261	24	1	only 4	CARDINAL
ajlm-1261	24	2	3.1%	PERCENT
ajlm-1261	27	1	4.05	CARDINAL
ajlm-1261	27	2	0.04	CARDINAL
ajlm-1261	27	3	more than 1 month	DATE
ajlm-1261	27	4	7.63	CARDINAL
ajlm-1261	27	5	0.02	CARDINAL
ajlm-1261	35	1	7.2%	PERCENT
ajlm-1261	35	2	95%	PERCENT
ajlm-1261	35	3	5.1–9.3%	PERCENT
ajlm-1261	35	4	6.3%	PERCENT
ajlm-1261	35	5	95%	PERCENT
ajlm-1261	35	6	5.4–7.3%	PERCENT
ajlm-1261	35	7	africa	LOC
ajlm-1261	35	8	second	ORDINAL
ajlm-1261	35	9	africa	LOC
ajlm-1261	35	10	between 25% and 60%	PERCENT
ajlm-1261	35	11	15–46	CARDINAL
ajlm-1261	35	12	ulcers.6 more than 1 million	MONEY
ajlm-1261	35	13	yearly	DATE
ajlm-1261	36	1	at least three	CARDINAL
ajlm-1261	36	2	charcot	PERSON
ajlm-1261	36	3	cameroon	GPE
ajlm-1261	36	4	west africa	GPE
ajlm-1261	37	1	the obafemi awolowo university teaching hospitals	ORG
ajlm-1261	37	2	ladoke akintola university college of technology	ORG
ajlm-1261	37	3	lth	ORG
ajlm-1261	40	1	osun state	GPE
ajlm-1261	40	2	southwest nigeria	GPE
ajlm-1261	40	3	between july 2016	DATE
ajlm-1261	40	4	april 2017	DATE
ajlm-1261	41	1	three	CARDINAL
ajlm-1261	41	2	obafemi awolowo university teaching hospitals	ORG
ajlm-1261	41	3	wesley guild hospital	ORG
ajlm-1261	41	4	ladoke akintola university of technology teaching hospital	ORG
ajlm-1261	46	1	oxoid	ORG
ajlm-1261	46	2	basingstoke	ORG
ajlm-1261	46	3	hants	ORG
ajlm-1261	46	4	united kingdom	GPE
ajlm-1261	47	1	2	CARDINAL
ajlm-1261	47	2	5%	PERCENT
ajlm-1261	47	3	oxoid	ORG
ajlm-1261	47	4	basingstoke	ORG
ajlm-1261	47	5	hants	ORG
ajlm-1261	47	6	united kingdom	GPE
ajlm-1261	47	7	macconkey agar	PERSON
ajlm-1261	47	8	oxoid	ORG
ajlm-1261	47	9	basingstoke	ORG
ajlm-1261	47	10	hants	ORG
ajlm-1261	47	11	united kingdom	GPE
ajlm-1261	47	12	oxoid	ORG
ajlm-1261	47	13	basingstoke	ORG
ajlm-1261	47	14	hants	ORG
ajlm-1261	47	15	united kingdom	GPE
ajlm-1261	47	16	5%	PERCENT
ajlm-1261	47	17	1 µg/ml	QUANTITY
ajlm-1261	47	18	5 µg/ml	QUANTITY
ajlm-1261	47	19	100 µg/ml	QUANTITY
ajlm-1261	48	1	macconkey	PERSON
ajlm-1261	48	2	37 °	QUANTITY
ajlm-1261	48	3	24	CARDINAL
ajlm-1261	48	4	kanamycin	PERSON
ajlm-1261	48	5	75 µg/l	CARDINAL
ajlm-1261	48	6	5 µg/l	QUANTITY
ajlm-1261	48	7	80%	PERCENT
ajlm-1261	48	8	10%	PERCENT
ajlm-1261	48	9	10%	PERCENT
ajlm-1261	48	10	48	CARDINAL
ajlm-1261	48	11	5 days	DATE
ajlm-1261	48	12	chamber (sheldon manufacturing, inc.	ORG
ajlm-1261	48	13	cornelius	PERSON
ajlm-1261	48	14	oregon	GPE
ajlm-1261	48	15	united states	GPE
ajlm-1261	49	1	gram	CARDINAL
ajlm-1261	50	1	gram	CARDINAL
ajlm-1261	50	2	24e	CARDINAL
ajlm-1261	50	3	oxoid	ORG
ajlm-1261	50	4	basingstoke	ORG
ajlm-1261	50	5	hants	ORG
ajlm-1261	50	6	united kingdom	GPE
ajlm-1261	50	7	fisher	ORG
ajlm-1261	50	8	lexena	GPE
ajlm-1261	50	9	kansas	GPE
ajlm-1261	50	10	united states	GPE
ajlm-1261	51	1	coagulase	NORP
ajlm-1261	52	1	ana ii	PERSON
ajlm-1261	52	2	fisher	ORG
ajlm-1261	52	3	lexena	GPE
ajlm-1261	52	4	kansas	GPE
ajlm-1261	52	5	united states	GPE
ajlm-1261	53	1	gram	CARDINAL
ajlm-1261	54	1	25923	DATE
ajlm-1261	54	2	25922	CARDINAL
ajlm-1261	54	3	25285	DATE
ajlm-1261	54	4	27337	DATE
ajlm-1261	56	1	kirby-bauer	ORG
ajlm-1261	56	2	oxoid	ORG
ajlm-1261	56	3	basingstoke	ORG
ajlm-1261	56	4	hants	ORG
ajlm-1261	56	5	united kingdom	GPE
ajlm-1261	56	6	10	CARDINAL
ajlm-1261	56	7	cefuroxime	GPE
ajlm-1261	56	8	30	CARDINAL
ajlm-1261	56	9	30	CARDINAL
ajlm-1261	56	10	30	CARDINAL
ajlm-1261	56	11	20/10	CARDINAL
ajlm-1261	56	12	5	CARDINAL
ajlm-1261	56	13	30	CARDINAL
ajlm-1261	56	14	10	CARDINAL
ajlm-1261	56	15	10	CARDINAL
ajlm-1261	56	16	1.25	CARDINAL
ajlm-1261	56	17	µg/23.75	PERSON
ajlm-1261	56	18	cefoxitin	PERSON
ajlm-1261	56	19	30	CARDINAL
ajlm-1261	56	20	15	CARDINAL
ajlm-1261	57	1	10	CARDINAL
ajlm-1261	57	2	100	CARDINAL
ajlm-1261	57	3	30	CARDINAL
ajlm-1261	58	1	256–0.015 µg/ml	QUANTITY
ajlm-1261	58	2	oxoid	ORG
ajlm-1261	58	3	basingstoke	ORG
ajlm-1261	58	4	hants	ORG
ajlm-1261	58	5	united kingdom	GPE
ajlm-1261	59	1	gram	CARDINAL
ajlm-1261	59	2	oxoid	ORG
ajlm-1261	59	3	basingstoke	ORG
ajlm-1261	59	4	hants	ORG
ajlm-1261	59	5	united kingdom	GPE
ajlm-1261	59	6	ceftriaxone	GPE
ajlm-1261	59	7	30	CARDINAL
ajlm-1261	59	8	30	CARDINAL
ajlm-1261	59	9	cefotaxime	PERSON
ajlm-1261	59	10	30	CARDINAL
ajlm-1261	59	11	30	CARDINAL
ajlm-1261	59	12	20/10	CARDINAL
ajlm-1261	59	13	5	CARDINAL
ajlm-1261	59	14	10	CARDINAL
ajlm-1261	59	15	10	CARDINAL
ajlm-1261	59	16	30	CARDINAL
ajlm-1261	59	17	30	CARDINAL
ajlm-1261	59	18	1.25	CARDINAL
ajlm-1261	59	19	µg/23.75	PERSON
ajlm-1261	59	20	10	CARDINAL
ajlm-1261	59	21	100	CARDINAL
ajlm-1261	59	22	cefoxitin	PERSON
ajlm-1261	59	23	30	CARDINAL
ajlm-1261	59	24	10	CARDINAL
ajlm-1261	59	25	10	CARDINAL
ajlm-1261	60	1	0.5	CARDINAL
ajlm-1261	60	2	mueller-hinton	ORG
ajlm-1261	61	1	six	CARDINAL
ajlm-1261	62	1	oxoid	ORG
ajlm-1261	62	2	basingstoke	ORG
ajlm-1261	62	3	hants	ORG
ajlm-1261	62	4	united kingdom	GPE
ajlm-1261	63	1	18–24	CARDINAL
ajlm-1261	66	1	25922	CARDINAL
ajlm-1261	66	2	s. aureus	PERSON
ajlm-1261	66	3	25923	DATE
ajlm-1261	66	4	43300	DATE
ajlm-1261	67	1	at least one	CARDINAL
ajlm-1261	67	2	third	ORDINAL
ajlm-1261	67	3	30	CARDINAL
ajlm-1261	67	4	30	CARDINAL
ajlm-1261	67	5	30	CARDINAL
ajlm-1261	67	6	30	CARDINAL
ajlm-1261	67	7	30	CARDINAL
ajlm-1261	67	8	30	CARDINAL
ajlm-1261	67	9	30/10	CARDINAL
ajlm-1261	67	10	30/10	CARDINAL
ajlm-1261	68	1	5 mm	QUANTITY
ajlm-1261	68	2	one	CARDINAL
ajlm-1261	68	3	anjali et al	PERSON
ajlm-1261	69	1	at least one	CARDINAL
ajlm-1261	69	2	third	ORDINAL
ajlm-1261	69	3	25922	CARDINAL
ajlm-1261	69	4	0.5	CARDINAL
ajlm-1261	70	1	6 mm	QUANTITY
ajlm-1261	70	2	about 20	CARDINAL
ajlm-1261	70	3	up to five	CARDINAL
ajlm-1261	71	1	30	CARDINAL
ajlm-1261	72	1	37 °	QUANTITY
ajlm-1261	73	1	gram	CARDINAL
ajlm-1261	73	2	one	CARDINAL
ajlm-1261	73	3	carbapenem	PERSON
ajlm-1261	73	4	1	CARDINAL
ajlm-1261	73	5	5	CARDINAL
ajlm-1261	73	6	1.5%	PERCENT
ajlm-1261	73	7	agarose	GPE
ajlm-1261	73	8	kitchener	PERSON
ajlm-1261	73	9	ontario	GPE
ajlm-1261	73	10	canada	GPE
ajlm-1261	73	11	1x	CARDINAL
ajlm-1261	73	12	45 min	DATE
ajlm-1261	74	1	100	CARDINAL
ajlm-1261	74	2	100–1200	CARDINAL
ajlm-1261	75	1	1	CARDINAL
ajlm-1261	76	1	social sciences	ORG
ajlm-1261	76	2	20	CARDINAL
ajlm-1261	76	3	spss inc.	ORG
ajlm-1261	76	4	chicago	GPE
ajlm-1261	76	5	illinois	GPE
ajlm-1261	76	6	united states	GPE
ajlm-1261	80	1	less than 0.05	CARDINAL
ajlm-1261	81	1	ninety	CARDINAL
ajlm-1261	81	2	53	CARDINAL
ajlm-1261	81	3	37	DATE
ajlm-1261	81	4	93	CARDINAL
ajlm-1261	81	5	11-month	DATE
ajlm-1261	82	1	between 18 and 85 years	DATE
ajlm-1261	82	2	54.7 ±	PERCENT
ajlm-1261	82	3	12.8 years	DATE
ajlm-1261	83	1	93	CARDINAL
ajlm-1261	83	2	56	DATE
ajlm-1261	83	3	60.2%	PERCENT
ajlm-1261	83	4	at least 1 month	DATE
ajlm-1261	83	5	70	DATE
ajlm-1261	83	6	75.3%	PERCENT
ajlm-1261	84	1	sixty-six	CARDINAL
ajlm-1261	84	2	71.0%	PERCENT
ajlm-1261	84	3	wagner	ORG
ajlm-1261	84	4	3	CARDINAL
ajlm-1261	85	1	82.2%	PERCENT
ajlm-1261	85	2	the month	DATE
ajlm-1261	85	3	93.3%	PERCENT
ajlm-1261	85	4	2	CARDINAL
ajlm-1261	86	1	2	CARDINAL
ajlm-1261	86	2	osun state	GPE
ajlm-1261	86	3	nigeria	GPE
ajlm-1261	86	4	july 2016 to april 2017	DATE
ajlm-1261	87	1	more than a month	DATE
ajlm-1261	87	2	more than a month	DATE
ajlm-1261	87	3	2	CARDINAL
ajlm-1261	88	1	4.05	CARDINAL
ajlm-1261	88	2	95%	PERCENT
ajlm-1261	88	3	1.08–15.13	CARDINAL
ajlm-1261	88	4	more than a month	DATE
ajlm-1261	88	5	7.63	CARDINAL
ajlm-1261	88	6	ci	PERSON
ajlm-1261	88	7	1.64–35.39	DATE
ajlm-1261	89	1	33/70	CARDINAL
ajlm-1261	89	2	47.1%	PERCENT
ajlm-1261	89	3	53.4%	PERCENT
ajlm-1261	89	4	31/58	CARDINAL
ajlm-1261	89	5	18/58	CARDINAL
ajlm-1261	89	6	31.0%	PERCENT
ajlm-1261	89	7	13/58	CARDINAL
ajlm-1261	89	8	22.4%	PERCENT
ajlm-1261	90	1	5.11	CARDINAL
ajlm-1261	90	2	95%	PERCENT
ajlm-1261	90	3	1.23–29.67	CARDINAL
ajlm-1261	91	1	93	CARDINAL
ajlm-1261	91	2	90	CARDINAL
ajlm-1261	91	3	three	CARDINAL
ajlm-1261	91	4	three	CARDINAL
ajlm-1261	91	5	only 10	CARDINAL
ajlm-1261	91	6	10.8%	PERCENT
ajlm-1261	92	1	45	DATE
ajlm-1261	92	2	48.4%	PERCENT
ajlm-1261	92	3	two	CARDINAL
ajlm-1261	92	4	34	DATE
ajlm-1261	92	5	36.6%	PERCENT
ajlm-1261	92	6	three	CARDINAL
ajlm-1261	92	7	4	CARDINAL
ajlm-1261	92	8	4.3%	PERCENT
ajlm-1261	92	9	four	CARDINAL
ajlm-1261	93	1	218	CARDINAL
ajlm-1261	93	2	93	CARDINAL
ajlm-1261	93	3	2.34	CARDINAL
ajlm-1261	94	1	129	CARDINAL
ajlm-1261	94	2	59.2%	PERCENT
ajlm-1261	94	3	gram	CARDINAL
ajlm-1261	94	4	59	DATE
ajlm-1261	94	5	27.1%	PERCENT
ajlm-1261	94	6	gram	CARDINAL
ajlm-1261	94	7	29	CARDINAL
ajlm-1261	94	8	13.3%	PERCENT
ajlm-1261	94	9	only 1	CARDINAL
ajlm-1261	94	10	0.5%	PERCENT
ajlm-1261	95	1	s. aureus	PERSON
ajlm-1261	95	2	34	CARDINAL
ajlm-1261	95	3	15.6%	PERCENT
ajlm-1261	95	4	e. coli	PERSON
ajlm-1261	95	5	23	CARDINAL
ajlm-1261	95	6	10.6%	PERCENT
ajlm-1261	95	7	20	CARDINAL
ajlm-1261	95	8	9.2%	PERCENT
ajlm-1261	97	1	19	CARDINAL
ajlm-1261	97	2	8.7%	PERCENT
ajlm-1261	98	1	19	CARDINAL
ajlm-1261	98	2	8.7%	PERCENT
ajlm-1261	99	1	14	CARDINAL
ajlm-1261	99	2	6.4%	PERCENT
ajlm-1261	100	1	11	CARDINAL
ajlm-1261	100	2	5.0%	PERCENT
ajlm-1261	100	3	proteus mirabilis	ORG
ajlm-1261	100	4	10	CARDINAL
ajlm-1261	100	5	4.6%	PERCENT
ajlm-1261	100	6	9	CARDINAL
ajlm-1261	100	7	4.1%	PERCENT
ajlm-1261	102	1	7	CARDINAL
ajlm-1261	102	2	3.2%	PERCENT
ajlm-1261	102	3	6	CARDINAL
ajlm-1261	102	4	2.8%	PERCENT
ajlm-1261	102	5	3	CARDINAL
ajlm-1261	102	6	3	CARDINAL
ajlm-1261	102	7	osun state	GPE
ajlm-1261	102	8	nigeria	GPE
ajlm-1261	102	9	july 2016 to april 2017	DATE
ajlm-1261	103	1	gram	CARDINAL
ajlm-1261	103	2	69.5%	PERCENT
ajlm-1261	103	3	66.1%	PERCENT
ajlm-1261	103	4	40.1%	PERCENT
ajlm-1261	103	5	6.8%	PERCENT
ajlm-1261	103	6	10.2%	PERCENT
ajlm-1261	104	1	gram	CARDINAL
ajlm-1261	104	2	third	ORDINAL
ajlm-1261	104	3	56%	PERCENT
ajlm-1261	104	4	cefotaxime	PERSON
ajlm-1261	104	5	55%	PERCENT
ajlm-1261	104	6	48.1%	PERCENT
ajlm-1261	104	7	89%	PERCENT
ajlm-1261	104	8	54.3%	PERCENT
ajlm-1261	104	9	54.3%	PERCENT
ajlm-1261	105	1	6.4%	PERCENT
ajlm-1261	105	2	9.3%	PERCENT
ajlm-1261	105	3	12.4%	PERCENT
ajlm-1261	106	1	188	CARDINAL
ajlm-1261	106	2	121	CARDINAL
ajlm-1261	106	3	64.4%	PERCENT
ajlm-1261	106	4	one	CARDINAL
ajlm-1261	106	5	at least three	CARDINAL
ajlm-1261	106	6	4	CARDINAL
ajlm-1261	107	1	gpc	ORG
ajlm-1261	107	2	55.9%	PERCENT
ajlm-1261	107	3	68.2%	PERCENT
ajlm-1261	108	1	88.9%	PERCENT
ajlm-1261	108	2	84.6%	PERCENT
ajlm-1261	108	3	81.8%	PERCENT
ajlm-1261	108	4	73.7%	PERCENT
ajlm-1261	109	1	80%	PERCENT
ajlm-1261	109	2	82.9%	PERCENT
ajlm-1261	109	3	69.6%	PERCENT
ajlm-1261	109	4	16	CARDINAL
ajlm-1261	110	1	twelve	CARDINAL
ajlm-1261	110	2	35.3%	PERCENT
ajlm-1261	111	1	129 gnb	QUANTITY
ajlm-1261	111	2	43	DATE
ajlm-1261	111	3	33.3%	PERCENT
ajlm-1261	111	4	10 (7.8%	PERCENT
ajlm-1261	111	5	5	CARDINAL
ajlm-1261	112	1	54.6%	PERCENT
ajlm-1261	112	2	52.6%	PERCENT
ajlm-1261	112	3	52.6%	PERCENT
ajlm-1261	112	4	e. coli	PERSON
ajlm-1261	112	5	43.5%	PERCENT
ajlm-1261	113	1	1	CARDINAL
ajlm-1261	113	2	20.0%	PERCENT
ajlm-1261	113	3	providencia	ORG
ajlm-1261	114	1	1	CARDINAL
ajlm-1261	114	2	33.0%	PERCENT
ajlm-1261	114	3	morganella morganii	ORG
ajlm-1261	114	4	2	CARDINAL
ajlm-1261	114	5	28.6%	PERCENT
ajlm-1261	115	1	ampc β	PERSON
ajlm-1261	116	1	1	CARDINAL
ajlm-1261	116	2	5.3%	PERCENT
ajlm-1261	116	3	e. coli	PERSON
ajlm-1261	116	4	2	CARDINAL
ajlm-1261	116	5	8.7%	PERCENT
ajlm-1261	116	6	m. morganii	PERSON
ajlm-1261	116	7	1	CARDINAL
ajlm-1261	116	8	14.3%	PERCENT
ajlm-1261	117	1	carbapenem	PERSON
ajlm-1261	117	2	4	CARDINAL
ajlm-1261	117	3	44.4%	PERCENT
ajlm-1261	117	4	h. alvei	PERSON
ajlm-1261	117	5	2	CARDINAL
ajlm-1261	117	6	40.0%	PERCENT
ajlm-1261	117	7	3	CARDINAL
ajlm-1261	117	8	15.0%	PERCENT
ajlm-1261	117	9	m. morganii	PERSON
ajlm-1261	117	10	1	CARDINAL
ajlm-1261	117	11	14.3%	PERCENT
ajlm-1261	118	1	10	CARDINAL
ajlm-1261	118	2	only four	CARDINAL
ajlm-1261	118	3	h. alvei	PERSON
ajlm-1261	118	4	2/4	CARDINAL
ajlm-1261	118	5	a. baumannii	PERSON
ajlm-1261	118	6	2/4	CARDINAL
ajlm-1261	118	7	4	CARDINAL
ajlm-1261	118	8	osun state	GPE
ajlm-1261	118	9	nigeria	GPE
ajlm-1261	118	10	july 2016 to april 2017	DATE
ajlm-1261	119	1	5	CARDINAL
ajlm-1261	119	2	osun state	GPE
ajlm-1261	119	3	nigeria	GPE
ajlm-1261	119	4	july 2016 to april 2017	DATE
ajlm-1261	120	1	ten	CARDINAL
ajlm-1261	120	2	83.3%	PERCENT
ajlm-1261	120	3	12	CARDINAL
ajlm-1261	121	1	at least one	CARDINAL
ajlm-1261	121	2	86.0%	PERCENT
ajlm-1261	121	3	43	CARDINAL
ajlm-1261	122	1	30	CARDINAL
ajlm-1261	122	2	69.8%	PERCENT
ajlm-1261	123	1	27	CARDINAL
ajlm-1261	123	2	62.8%	PERCENT
ajlm-1261	123	3	8	CARDINAL
ajlm-1261	123	4	18.6%	PERCENT
ajlm-1261	123	5	6	CARDINAL
ajlm-1261	124	1	thirty-one	CARDINAL
ajlm-1261	124	2	72.1%	PERCENT
ajlm-1261	124	3	at least two	CARDINAL
ajlm-1261	125	1	four	CARDINAL
ajlm-1261	125	2	10	CARDINAL
ajlm-1261	126	1	four	CARDINAL
ajlm-1261	126	2	3	CARDINAL
ajlm-1261	126	3	2	CARDINAL
ajlm-1261	127	1	2/2	CARDINAL
ajlm-1261	127	2	a. baumannii	PERSON
ajlm-1261	127	3	2/2	CARDINAL
ajlm-1261	128	1	6	CARDINAL
ajlm-1261	128	2	osun state	GPE
ajlm-1261	128	3	nigeria	GPE
ajlm-1261	128	4	july 2016 to april 2017	DATE
ajlm-1261	131	1	two	CARDINAL
ajlm-1261	131	2	africa	LOC
ajlm-1261	131	3	asia.29 gram-negative	QUANTITY
ajlm-1261	131	4	e. coli	PERSON
ajlm-1261	131	5	gram	CARDINAL
ajlm-1261	131	6	diseases.29	ORG
ajlm-1261	131	7	third	ORDINAL
ajlm-1261	132	1	13.3%	PERCENT
ajlm-1261	134	1	jos	GPE
ajlm-1261	134	2	nigeria	GPE
ajlm-1261	134	3	17%),33	CARDINAL
ajlm-1261	134	4	al-benwan	PERSON
ajlm-1261	134	5	kuwait	GPE
ajlm-1261	134	6	15.3%).34	CARDINAL
ajlm-1261	134	7	richard et al	PERSON
ajlm-1261	135	1	1%)35	ORDINAL
ajlm-1261	135	2	france	GPE
ajlm-1261	135	3	yates et al	PERSON
ajlm-1261	136	1	1%)36	CARDINAL
ajlm-1261	136	2	australia	GPE
ajlm-1261	136	3	74/93	CARDINAL
ajlm-1261	136	4	80%	PERCENT
ajlm-1261	136	5	france	GPE
ajlm-1261	136	6	africa	LOC
ajlm-1261	136	7	asia	LOC
ajlm-1261	136	8	one	CARDINAL
ajlm-1261	136	9	three	CARDINAL
ajlm-1261	137	1	africa	LOC
ajlm-1261	137	2	50%.44	CARDINAL
ajlm-1261	137	3	meca	PERSON
ajlm-1261	137	4	s. aureus	PERSON
ajlm-1261	137	5	83.3%	PERCENT
ajlm-1261	137	6	chaudhry et al	PERSON
ajlm-1261	137	7	20 (84%	PERCENT
ajlm-1261	137	8	25	CARDINAL
ajlm-1261	137	9	meca	PERSON
ajlm-1261	137	10	meca	PERSON
ajlm-1261	137	11	2011	DATE
ajlm-1261	137	12	33.3%	PERCENT
ajlm-1261	137	13	two	CARDINAL
ajlm-1261	137	14	e. coli	PERSON
ajlm-1261	138	1	23% to 49%	PERCENT
ajlm-1261	138	2	africa	LOC
ajlm-1261	138	3	only 10	CARDINAL
ajlm-1261	138	4	7.8%	PERCENT
ajlm-1261	138	5	gram	CARDINAL
ajlm-1261	139	1	carbapenem resistance	PERSON
ajlm-1261	139	2	a. baumannii	PERSON
ajlm-1261	139	3	h. alvei	PERSON
ajlm-1261	139	4	m. morganii	PERSON
ajlm-1261	140	1	longer than a month	DATE
ajlm-1261	143	1	1 month	DATE
ajlm-1261	143	2	india.40,51,52	CARDINAL
ajlm-1261	143	3	china	GPE
ajlm-1261	143	4	iran	GPE
ajlm-1261	143	5	noor et al	PERSON
ajlm-1261	143	6	1 month	DATE
ajlm-1261	143	7	trivedi et al	PERSON
ajlm-1261	144	1	the united states	GPE
ajlm-1261	144	2	infection.56	LANGUAGE
ajlm-1261	145	1	28	CARDINAL
ajlm-1261	145	2	22.7%	PERCENT
ajlm-1261	145	3	failure.57	ORG
ajlm-1261	145	4	90	CARDINAL
ajlm-1261	150	1	babatunde odetoyin	ORG
ajlm-1261	150	2	obafemi awolowo university	ORG
ajlm-1261	150	3	nigeria	GPE
ajlm-1261	155	1	b.k.	PERSON
ajlm-1261	166	1	the obafemi awolowo university teaching hospitals	ORG
ajlm-1261	169	1	lipsky ba	PERSON
ajlm-1261	169	2	abbas zg	PERSON
ajlm-1261	170	1	2019	DATE
ajlm-1261	172	1	2020;36(s1):e3280	CARDINAL
ajlm-1261	172	2	https://doi.org/10.1002/dmrr.3280 zhang p	PERSON
ajlm-1261	172	3	lu j	PERSON
ajlm-1261	174	1	ann med.	PERSON
ajlm-1261	175	1	2017	CARDINAL
ajlm-1261	176	1	ea	CARDINAL
ajlm-1261	177	1	africa	LOC
ajlm-1261	178	1	lancet	ORG
ajlm-1261	179	1	2015	CARDINAL
ajlm-1261	180	1	https://doi.org/10.1016/s2213-8587(15)00236-3 jia l	ORG
ajlm-1261	180	2	parker cn	PERSON
ajlm-1261	180	3	parker tj	PERSON
ajlm-1261	181	1	jan y-k	DATE
ajlm-1261	182	1	plos	PERSON
ajlm-1261	182	2	one	CARDINAL
ajlm-1261	183	1	2017;12(5):e0177916	CARDINAL
ajlm-1261	184	1	j. foot	PERSON
ajlm-1261	184	2	105	CARDINAL
ajlm-1261	184	3	nigerian	NORP
ajlm-1261	184	4	africans	NORP
ajlm-1261	185	1	diab	PERSON
ajlm-1261	185	2	j. 2008;11(1):36–42	PERSON
ajlm-1261	185	3	alavi sm	PERSON
ajlm-1261	185	4	khosravi	ORG
ajlm-1261	185	5	dashtebozorg	ORG
ajlm-1261	185	6	bacteriologic study of	ORG
ajlm-1261	186	1	pakistan	GPE
ajlm-1261	186	2	med sci	PERSON
ajlm-1261	187	1	2007;23(5):681–684	CARDINAL
ajlm-1261	188	1	khanolkar mp	PERSON
ajlm-1261	188	2	bain sc	ORG
ajlm-1261	188	3	stephens jw	PERSON
ajlm-1261	190	1	j med	PERSON
ajlm-1261	191	1	2008;101(9):685–695	CARDINAL
ajlm-1261	192	1	https://doi.org/10.1093/qjmed/hcn027 lipsky ba	PERSON
ajlm-1261	192	2	berendt ar	PERSON
ajlm-1261	192	3	cornia pb	GPE
ajlm-1261	194	1	clin	PERSON
ajlm-1261	195	1	2012;54(12):132–173	ORDINAL
ajlm-1261	197	1	1	CARDINAL
ajlm-1261	198	1	therap	PERSON
ajlm-1261	199	1	2015;40(4):277–283	CARDINAL
ajlm-1261	200	1	magiorakos ap	PERSON
ajlm-1261	200	2	srinivasan a	ORG
ajlm-1261	200	3	carey	PERSON
ajlm-1261	201	1	clin microb	PERSON
ajlm-1261	202	1	2012;18(3):268–281	CARDINAL
ajlm-1261	202	2	laxminarayan r	ORG
ajlm-1261	202	3	pant s	ORG
ajlm-1261	203	1	lancet	ORG
ajlm-1261	204	1	2016 jan 9;387(10014):168–175	DATE
ajlm-1261	205	1	https://doi.org/10.1016/s0140-6736(15)00474-2 serra-burriel	PERSON
ajlm-1261	206	1	plos one	PERSON
ajlm-1261	208	1	di leo m	PERSON
ajlm-1261	212	1	kandemir ö	PERSON
ajlm-1261	212	2	şahin e	GPE
ajlm-1261	212	3	gen r. risk	PERSON
ajlm-1261	214	1	2007;54(5):439–445	CARDINAL
ajlm-1261	215	1	shahi sk	PERSON
ajlm-1261	215	2	kumar s	PERSON
ajlm-1261	215	3	singh	GPE
ajlm-1261	215	4	gupta sk	PERSON
ajlm-1261	215	5	singh	GPE
ajlm-1261	216	1	north india	LOC
ajlm-1261	217	1	j diab foot compl	PERSON
ajlm-1261	218	1	2012;4(4):83–91	DATE
ajlm-1261	219	1	kaur n	PERSON
ajlm-1261	219	2	kaur n	PERSON
ajlm-1261	219	3	kumar r	PERSON
ajlm-1261	219	4	gill ak	ORG
ajlm-1261	222	1	vasnessa pds	PERSON
ajlm-1261	222	2	denise rds	PERSON
ajlm-1261	222	3	roberto ac	PERSON
ajlm-1261	223	1	sao paulo med j. 2006;124(2):66–70	PERSON
ajlm-1261	224	1	adeleye jo	PERSON
ajlm-1261	225	1	nigerian	NORP
ajlm-1261	226	1	pract diab	PERSON
ajlm-1261	227	1	2005;22(6):211–214	CARDINAL
ajlm-1261	228	1	bekele k.	PERSON
ajlm-1261	228	2	nekemte referral hospital	ORG
ajlm-1261	228	3	ethiopia	GPE
ajlm-1261	229	1	ann med surg	PERSON
ajlm-1261	231	1	longo m	PERSON
ajlm-1261	231	2	gicchino m	ORG
ajlm-1261	231	3	scappaticcio l	PERSON
ajlm-1261	231	4	caputo m	PERSON
ajlm-1261	233	1	diab	PERSON
ajlm-1261	233	2	clin pract	PERSON
ajlm-1261	235	1	https://doi.org/10.1016/j.diabres.2020.108147 clsi	PERSON
ajlm-1261	237	1	twenty-fifth	CARDINAL
ajlm-1261	238	1	clsi	PERSON
ajlm-1261	238	2	m100-s25	ORG
ajlm-1261	238	3	wayne	PERSON
ajlm-1261	238	4	2015	DATE
ajlm-1261	239	1	gram	CARDINAL
ajlm-1261	240	1	inter j med health sci	ORG
ajlm-1261	242	1	sidjabat	PERSON
ajlm-1261	242	2	paterson dl	PERSON
ajlm-1261	242	3	adams-haduch jm	PERSON
ajlm-1261	243	1	western pennsylvania	LOC
ajlm-1261	244	1	antimicrob	PERSON
ajlm-1261	245	1	2009;53(11):4733–4739	CARDINAL
ajlm-1261	246	1	monstein hj	PERSON
ajlm-1261	246	2	nilsson mv	ORG
ajlm-1261	247	1	multiplex pcr amplification	PERSON
ajlm-1261	247	2	shv	ORG
ajlm-1261	247	3	tem	ORG
ajlm-1261	248	1	apmis	ORG
ajlm-1261	249	1	https://doi.org/10.1111/j.1600-0463.2007.00722.x pasanen t	PERSON
ajlm-1261	250	1	multiplex	PRODUCT
ajlm-1261	251	1	plos	PERSON
ajlm-1261	251	2	one	CARDINAL
ajlm-1261	252	1	2014;9(1):e85854	CARDINAL
ajlm-1261	253	1	https://doi.org/10.1371/journal.pone.0085854 zhao s	PERSON
ajlm-1261	255	1	east india	LOC
ajlm-1261	256	1	ann clin microbiol	PERSON
ajlm-1261	256	2	antimicrob	PERSON
ajlm-1261	257	1	2015;14:7	PERSON
ajlm-1261	258	1	khan aks	PERSON
ajlm-1261	258	2	shetty pj	PERSON
ajlm-1261	258	3	sarayu yl	PERSON
ajlm-1261	258	4	ranganathan r. detection	PERSON
ajlm-1261	258	5	meca	ORG
ajlm-1261	259	1	jadaon mm	PERSON
ajlm-1261	259	2	abdulsamad	PERSON
ajlm-1261	260	1	kuwait	GPE
ajlm-1261	260	2	j. 2009;41(2):117–122	ORG
ajlm-1261	260	3	zubair m.	PERSON
ajlm-1261	263	1	jimoh ak	ORG
ajlm-1261	263	2	adekoya ao	PERSON
ajlm-1261	263	3	busari oa	PERSON
ajlm-1261	263	4	olokoba ab	PERSON
ajlm-1261	264	1	three	CARDINAL
ajlm-1261	264	2	nigeria	GPE
ajlm-1261	265	1	ghana	GPE
ajlm-1261	265	2	j. 2011;45(2):60–65	PERSON
ajlm-1261	266	1	mendes jj	PERSON
ajlm-1261	267	1	j diab foot	PERSON
ajlm-1261	268	1	2012;4(1):26–45	TIME
ajlm-1261	269	1	nai ka	PERSON
ajlm-1261	269	2	ikem ci	PERSON
ajlm-1261	269	3	akinloye	PERSON
ajlm-1261	269	4	kassim	PERSON
ajlm-1261	270	1	nigeria	GPE
ajlm-1261	272	1	2006;16(3):158–164	CARDINAL
ajlm-1261	273	1	puepet f	PERSON
ajlm-1261	273	2	jos university teaching hospital	ORG
ajlm-1261	273	3	nigeria	GPE
ajlm-1261	274	1	afr j clin exp microb	PERSON
ajlm-1261	275	1	2003;4(2):52–61	GPE
ajlm-1261	276	1	https://doi.org/10.4314/ajcem.v4i1.7324 al-benwan	GPE
ajlm-1261	276	2	al mulla	PERSON
ajlm-1261	277	1	kuwait	GPE
ajlm-1261	279	1	2012;5(1):1–8	PERSON
ajlm-1261	280	1	richard jl	PERSON
ajlm-1261	280	2	lavigne jp	PERSON
ajlm-1261	280	3	french	NORP
ajlm-1261	282	1	2011;37(3):208–15	CARDINAL
ajlm-1261	283	1	k, hale t	ORG
ajlm-1261	283	2	allard b	ORG
ajlm-1261	283	3	freeman	PERSON
ajlm-1261	286	1	oecd	ORG
ajlm-1261	286	2	june 27, 2013	DATE
ajlm-1261	287	1	oecd	ORG
ajlm-1261	288	1	oecd	ORG
ajlm-1261	289	1	paris	GPE
ajlm-1261	290	1	oecd	ORG
ajlm-1261	290	2	richard jl	PERSON
ajlm-1261	290	3	jourdan n	PERSON
ajlm-1261	291	1	diab metab	PERSON
ajlm-1261	292	1	2008;34(2):363–369	CARDINAL
ajlm-1261	293	1	https://doi.org/10.1016/j.diabet.2008.02.005	CARDINAL
ajlm-1261	293	2	oe	DATE
ajlm-1261	293	3	afolabi ao	PERSON
ajlm-1261	293	4	afolabi ot	PERSON
ajlm-1261	293	5	nigerian	NORP
ajlm-1261	294	1	ann ibadan	PERSON
ajlm-1261	296	1	dhawan b	PERSON
ajlm-1261	296	2	sreenivas v	PRODUCT
ajlm-1261	296	3	kapil	PERSON
ajlm-1261	296	4	amini ac	PERSON
ajlm-1261	296	5	chaudhry ra	PERSON
ajlm-1261	297	1	indian	NORP
ajlm-1261	300	1	m. determination	PERSON
ajlm-1261	301	1	iranian	NORP
ajlm-1261	303	1	mendes jj	PERSON
ajlm-1261	304	1	lisbon	GPE
ajlm-1261	305	1	diab	PERSON
ajlm-1261	305	2	clin pract	PERSON
ajlm-1261	306	1	2012;95(1):153–161	CARDINAL
ajlm-1261	307	1	dwedar r	PERSON
ajlm-1261	307	2	ismail dk	PERSON
ajlm-1261	307	3	abdulbaky a.	PERSON
ajlm-1261	308	1	egyptian	NORP
ajlm-1261	308	2	j med microbiol	PERSON
ajlm-1261	309	1	karageorgopoulos de	PERSON
ajlm-1261	309	2	korbila	PERSON
ajlm-1261	309	3	africa	LOC
ajlm-1261	310	1	plos	PERSON
ajlm-1261	310	2	one	CARDINAL
ajlm-1261	311	1	2013;8(7):e68024	CARDINAL
ajlm-1261	312	1	chaudhry wn	PERSON
ajlm-1261	312	2	badar r	PERSON
ajlm-1261	312	3	jamal m	PERSON
ajlm-1261	312	4	jeong j	PERSON
ajlm-1261	312	5	zafar j	PERSON
ajlm-1261	312	6	andleeb s. clinico-microbiological	PERSON
ajlm-1261	312	7	meca	PERSON
ajlm-1261	313	1	2016;11(3):1031–1038	CARDINAL
ajlm-1261	314	1	ac	ORG
ajlm-1261	314	2	deasy ec	PERSON
ajlm-1261	315	1	meca	ORG
ajlm-1261	315	2	mecr1	PERSON
ajlm-1261	315	3	blaz	ORG
ajlm-1261	315	4	ccr	ORG
ajlm-1261	315	5	130	CARDINAL
ajlm-1261	316	1	antimicrob	PERSON
ajlm-1261	318	1	dogra j	PERSON
ajlm-1261	318	2	kulkarni m	PERSON
ajlm-1261	320	1	indian	NORP
ajlm-1261	321	1	2008;26(3):281–282	CARDINAL
ajlm-1261	325	1	https://doi.org/10.1016/j.ijid.2018.02.013 shaikh s	PERSON
ajlm-1261	325	2	fatima j	PERSON
ajlm-1261	325	3	rizvi smd	PERSON
ajlm-1261	325	4	kamal ma	PERSON
ajlm-1261	327	1	saudi	NORP
ajlm-1261	327	2	biol sci	PERSON
ajlm-1261	328	1	2015;22(1):90–101	CARDINAL
ajlm-1261	329	1	levin	PERSON
ajlm-1261	331	1	j. diab dev countr	PERSON
ajlm-1261	332	1	valappil rk	PERSON
ajlm-1261	332	2	krishnan s	PERSON
ajlm-1261	332	3	bai sdk.	ORG
ajlm-1261	334	1	sci clin res	ORG
ajlm-1261	335	1	2017;9(2):18138–18143	CARDINAL
ajlm-1261	336	1	https://doi.org/10.18535/jmscr/v5i2.144 zubair m	PERSON
ajlm-1261	336	2	abida m	PERSON
ajlm-1261	336	3	jamal a. clinicobacteriology	PERSON
ajlm-1261	336	4	north india	LOC
ajlm-1261	338	1	2010;2(4):22–34	CARDINAL
ajlm-1261	338	2	robert j	PERSON
ajlm-1261	341	1	borse ag	ORG
ajlm-1261	341	2	ozair m	ORG
ajlm-1261	341	3	raghav	PERSON
ajlm-1261	341	4	ahmad j.	PERSON
ajlm-1261	343	1	2017;32:44–48	CARDINAL
ajlm-1261	344	1	jin p	PERSON
ajlm-1261	344	2	chu y	PERSON
ajlm-1261	344	3	feng s	PERSON
ajlm-1261	344	4	wang	PERSON
ajlm-1261	346	1	2014;13(1):64–71	CARDINAL
ajlm-1261	347	1	trivedi u	PERSON
ajlm-1261	347	2	parameswaran s	PERSON
ajlm-1261	350	1	2014;2014:173053	CARDINAL
ajlm-1261	351	1	http://doi.org/10.1155/2014/173053 vardakas kz	ORG
ajlm-1261	353	1	clin pract	ORG
ajlm-1261	354	1	2008;80:344–351	CARDINAL